According to the latest figures released by Congolese health authorities on Monday, the outbreak has killed 2,911 people, while 1,366 patients have recovered from the 6,041 confirmed cases recorded so far.
The scale of the outbreak has surpassed the toll from the country’s 2018–2020 Ebola epidemic, previously regarded as the worst Ebola crisis in the DRC.
The latest outbreak is being driven by the Bundibugyo strain of the Ebola virus, a particularly challenging development for health authorities because there is currently no approved vaccine or specific treatment for the strain.
The virus has spread rapidly across six provinces in northern and eastern parts of the country, including areas already grappling with prolonged insecurity and the activities of numerous armed groups.
The eastern DRC is one of the country’s most volatile regions, with decades of conflict, displacement and weak state presence creating additional obstacles for public health workers attempting to contain infectious diseases.
At the Rwampara Ebola Treatment Centre (ETC) in Bunia, Ituri province, health workers have been carrying out intensive infection-control measures as they attempt to contain the outbreak.
A hygienist wearing personal protective equipment (PPE) was photographed conducting cleaning and disinfection operations at the treatment centre on July 13, underscoring the demanding conditions under which medical and support personnel are working.
The response has been further complicated by inadequate funding. Health authorities and humanitarian organisations have struggled to expand their operations quickly enough to match the rapid rise in infections.
Beyond shortages of resources, responders are facing another major obstacle: mistrust.
In many parts of the outbreak’s epicentre, the government has historically had a limited presence, while years of conflict have deepened suspicion of state institutions. Health workers therefore have to navigate not only the medical challenges of Ebola but also resistance and distrust among some communities.
The Bundibugyo strain presents an additional challenge because its early symptoms can appear relatively mild, according to Congolese health authorities.
That characteristic can make it more difficult to identify infected people at an early stage, potentially allowing transmission to continue before patients are diagnosed and isolated.
Most previous Ebola outbreaks in the DRC have been caused by the Zaire strain, against which vaccines and treatments have been developed and deployed.
The absence of an approved vaccine or specific treatment for Bundibugyo has consequently increased concern among health officials and medical researchers.
Several vaccines and treatments are now being tested to determine whether they can provide protection or therapeutic benefits against the strain.
With the outbreak continuing to put pressure on an already underfunded response system, health authorities face the difficult task of expanding surveillance, treatment, infection prevention and community engagement while operating in regions affected by persistent violence.
The rising toll has placed renewed focus on the need for greater international support as the DRC confronts its most devastating Ebola epidemic to date.